Despite being a driver in several key oncogenic processes, the potential functions of LINC00152 in regulating distinct forms of cell death, such as ferroptosis to drive resistance to endocrine therapy, including tamoxifen in ER+ breast cancer remain to be elucidated. The gene discussed is ESR1; the disease is breast carcinoma.